Before the internet made book reviews widely accessible, where would curious minds go to find information about a new novel's subject matter or a plot? If you lived in the Los Angeles area, you ...

Reeves and Pfeiffer fully understand the task of retaining the Sky Room’s long history and heritage while also grasping that for it to succeed, they had to reinvent it. “Even I admit that I ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $30.00. See what stocks are receiving Strong ...

Sony mastered this game decades ago. From humble post-war beginnings to global domination, Sony's logo evolution isn't just design history—it's a masterclass in building unshakeable brand power that ...

Join the Department of Pan-African Studies for a Black History Month talk on "Black LA and the Black Student Movement, 1960s-1970s." This talk will explore the role of Black Student Activism in ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases by the CEO and director. This comes as a significant ...

Frustrations over the exclusion of women from America’s national narrative boiled over in the 1970s—leading to the creation of Women’s History Month. Observed throughout the United States ...

Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting ...

Feb 28 (Reuters) - Britain's health regulator said on Friday it has approved Moderna's (MRNA.O), opens new tab vaccine for respiratory syncytial virus in adults 60 years and older. The shot ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources. Shares of ...

(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.